| Literature DB >> 31824999 |
Jong-Jin Yun1, Eun-Young Kim1, Eun-Jung Ahn1, Jeong-Ki Kim1, Ji-Hye Choi1, Jong-Min Park1, Sei Hyeog Park1.
Abstract
BACKGROUNDS/AIMS: Laparoscopic cholecystectomy (LC) has become widely used and preferred standard treatment for gallbladder (GB) disease in many countries. In this study, we aimed to compare the overall clinical outcomes of 3-dimensional (3D) LC system with those of the 2D LC method.Entities:
Keywords: 2D laparoscopic cholecystectomy; 3D laparoscopic cholecystectomy; Acute cholecystitis; Gallbladder
Year: 2019 PMID: 31824999 PMCID: PMC6893058 DOI: 10.14701/ahbps.2019.23.4.339
Source DB: PubMed Journal: Ann Hepatobiliary Pancreat Surg ISSN: 2508-5859
Preoperative patient characteristics
Values are numbers (percentages) unless otherwise stated
ASA, American Society of Anesthesiologists; BMI, Body Mass Index; PTGBD, Percutaneous Transhepatic Gallbladder Drainage; WBC, White Blood Cell; AST, Aspartate aminotransferase; ALT, Alanine aminotransferase
*Values are mean
Surgical history according to 3D LC vs. 2D LC
Values are numbers (percentages) unless otherwise stated
*Abdominal: appendectomy, C-section, hysterectomy, abdominal cancer surgery, and primary stomach repair
**Non-abdominal: thyroidectomy, hemorrhoidectomy, and orthopedic surgery
Underlying diseases according to 3D LC vs. 2D LC
Values are numbers (percentages) unless otherwise stated
*Serious comorbidities: cardiovascular disease, chronic kidney disease requiring hemodialysis, chronic obstructive pulmonary disease, cerebrovascular disease, liver cirrhosis
Surgical outcomes according to 3D LC vs. 2D LC
Values are numbers (percentages) unless otherwise stated
*Values are mean